BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27830724)

  • 21. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells.
    Ge R; Wang Z; Wu S; Zhuo Y; Otsetov AG; Cai C; Zhong W; Wu CL; Olumi AF
    Oncotarget; 2015 Oct; 6(30):28973-87. PubMed ID: 26359363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Hahn SS; Tang Q; Zheng F; Zhao S; Wu J; Chen J
    Cell Signal; 2014 Mar; 26(3):639-47. PubMed ID: 24361375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
    Babcook MA; Sramkoski RM; Fujioka H; Daneshgari F; Almasan A; Shukla S; Nanavaty RR; Gupta S
    Cell Death Dis; 2014 Nov; 5(11):e1536. PubMed ID: 25412314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of HAART on the expression of MUC1 and P65 in a cervical cancer cell line, HCS-2.
    Thabethe KR; Adefolaju GA; Hosie MJ
    Biomed Pharmacother; 2015 Apr; 71():227-32. PubMed ID: 25960241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation and interaction of colon cancer-associated transcript-1 and miR7-5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells.
    Wu J; Tang X; Ma C; Shi Y; Wu W; Hann SS
    Phytother Res; 2020 Jan; 34(1):201-213. PubMed ID: 31823440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation.
    Moiseeva O; Deschênes-Simard X; St-Germain E; Igelmann S; Huot G; Cadar AE; Bourdeau V; Pollak MN; Ferbeyre G
    Aging Cell; 2013 Jun; 12(3):489-98. PubMed ID: 23521863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun.
    Tang Q; Zhao S; Wu J; Zheng F; Yang L; Hu J; Hann SS
    Cell Signal; 2015 Jul; 27(7):1469-77. PubMed ID: 25889897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
    Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
    Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.
    Kong Y; Zhang Y; Mao F; Zhang Z; Li Z; Wang R; Liu J; Liu X
    Mol Cancer Ther; 2020 Dec; 19(12):2490-2501. PubMed ID: 33024029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells.
    Xie X; Zhang X; Chen J; Tang X; Wang M; Zhang L; Guo Z; Shen W
    Int J Oncol; 2019 Mar; 54(3):905-915. PubMed ID: 30483763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line.
    Thathiah A; Brayman M; Dharmaraj N; Julian JJ; Lagow EL; Carson DD
    Endocrinology; 2004 Sep; 145(9):4192-203. PubMed ID: 15142990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ser-486/491 phosphorylation and inhibition of AMPKα activity is positively associated with Gleason score, metastasis, and castration-resistance in prostate cancer: A retrospective clinical study.
    Babcook MA; Akgul M; Margevicius S; MacLennan GT; Fu P; Abouassaly R; Gupta S
    Prostate; 2018 Jul; 78(10):714-723. PubMed ID: 29577356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.
    Cascio S; Zhang L; Finn OJ
    J Biol Chem; 2011 Dec; 286(49):42248-42256. PubMed ID: 22021035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition.
    Burger T; Mokoka T; Fouché G; Steenkamp P; Steenkamp V; Cordier W
    BMC Complement Altern Med; 2018 May; 18(1):137. PubMed ID: 29720141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
    Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer Properties of Solamargine: A Systematic Review.
    Kalalinia F; Karimi-Sani I
    Phytother Res; 2017 Jun; 31(6):858-870. PubMed ID: 28383149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells.
    Mayer MJ; Klotz LH; Venkateswaran V
    Anticancer Res; 2017 Dec; 37(12):6601-6607. PubMed ID: 29187435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.